ClinicalTrials.Veeva

Menu

Effect of Vitamin D3 and Omega-3FA on Leptin and HbA1C With Vitamin D Deficiency

A

Applied Science Private University

Status

Completed

Conditions

Vitamin D Deficiency

Treatments

Dietary Supplement: VD3 and omega- 3FA group
Dietary Supplement: omega 3 FA group
Dietary Supplement: VD3 group
Other: control group

Study type

Interventional

Funder types

Other

Identifiers

NCT03735303
DRGS-4-2018

Details and patient eligibility

About

The Combined effect of Vitamin D3 and Omega-3 supplements on serum leptin and Glycated hemoglobin (Hb A1C) levels in Jordanian people with vitamin D deficiency.

Full description

Nothing is published in the literature about effect of vitamin D3 (VD3) and omega-3 fatty acids (omega-3FA) on serum leptin and glycated hemoglobin ( HbA1C)

This study will be conducted to investigate effect of VD3 and omega-3FA alone and with each other on serum leptin and Glycated hemoglobin (Hb A1C) levels in Jordanian people with vitamin D deficiency.

This randomized, controlled clinical trial will be designed to test effects of 50,000 IU VD3 weekly and 1000 mg omega-3FA daily for eight weeks, separately and with each other, on on serum leptin and Glycated hemoglobin (Hb A1C) levels .

Enrollment

146 patients

Sex

All

Ages

25 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • jordanian people aged 25-55
  • medical diagnosis of vitamin D deficiency ( VD <25 ng/ ml)

Exclusion criteria

  • Blood disorders including
  • thalassemia
  • sickle cell disease

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

146 participants in 4 patient groups

VD3 group
Experimental group
Description:
dietary supplement : VD3 group treated with 50000 IU VD3/ week for 8 weeks
Treatment:
Dietary Supplement: VD3 group
omega 3- FA group
Experimental group
Description:
dietary supplement : omega 3- FA group 1000 mg wild salmon and fish oil complex (contain 300 mg of omega 3-FA) once daily for 8 weeks
Treatment:
Dietary Supplement: omega 3 FA group
VD3 and omega 3 FA group
Experimental group
Description:
dietary supplement : VD3 and omega-3FA 50000 IU VD3/week for 8 weeks and 1000 mg wild salmon and fish oil complex (contain 300 mg of omega 3-FA) once daily for 8 weeks
Treatment:
Dietary Supplement: VD3 and omega- 3FA group
control group
Experimental group
Description:
no intervention was given
Treatment:
Other: control group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems